I think it is cheap, a good play on the recovery, and it has pulled back to a very good entry point.
This morning, BAC/Merrill initiated the stock with a neutral rating; I think that is wrong. I'd buy it here.
But here's the report, along with their morning research.
You can make your own judgment.
bas5
No comments:
Post a Comment